Solution structure and basis for functional activity of stromal cell-derived factor-1; dissociation of CXCR4 activation from binding and inhibition of HIV-1

被引:650
作者
Crump, MP
Gong, JH
Loetscher, P
Rajarathnam, K
Amara, A
Arenzana-Seisdedos, F
Virelizier, JL
Baggiolini, M
Sykes, BD
Clark-Lewis, I
机构
[1] Univ British Columbia, Biomed Res Ctr, Vancouver, BC V6T 1Z3, Canada
[2] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z3, Canada
[3] Univ Bern, Theodor Kocher Inst, Bern 9, Switzerland
[4] Inst Pasteur, Unite Immunol Virale, F-75724 Paris 15, France
[5] Univ Alberta, PENCE, Heritage Med Res Ctr 713, Edmonton, AB T6G 2S2, Canada
[6] Univ Alberta, Dept Biochem, Heritage Med Res Ctr 713, Edmonton, AB T6G 2S2, Canada
关键词
chemokines; G-protein coupled receptors; nuclear magnetic resonance spectroscopy; protein synthesis; stromal cell-derived factor-1;
D O I
10.1093/emboj/16.23.6996
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The three-dimensional structure of stromal cell-derived factor-1 (SDF-1) was determined by NMR spectroscopy, SDF-1 is a monomer with a disordered N-terminal region (residues 1-8), and differs from other chemokines in the packing of the hydrophobic core and surface charge distribution, Results with analogs showed that the N-terminal eight residues formed an important receptor binding site; however, only Lys-1 and Pro-2 were directly involved in receptor activation, Modification to Lys-1 and/or Pro-2 resulted in loss of activity, but generated potent SDF-1 antagonists, Residues 12-17 of the loop region, which we term the RFFESH motif, unlike the N-terminal region, were well defined in the SDF-1 structure, The RFFESH formed a receptor binding site, which we propose to be an important initial docking site of SDF-1 with its receptor, The ability of the SDF-1 analogs to block HIV-1 entry via CXCR4, which is a HIV-1 coreceptor for the virus in addition to being the receptor for SDF-1, correlated with their affinity for CXCR4, Activation of the receptor is not required for HIV-1 inhibition.
引用
收藏
页码:6996 / 7007
页数:12
相关论文
共 42 条
[1]   The chemokine SDF-1 is a chemoattractant for human CD34(+) hematopoietic progenitor cells and provides a new mechanism to explain the mobilization of CD34(+) progenitors to peripheral blood [J].
Aiuti, A ;
Webb, IJ ;
Bleul, C ;
Springer, T ;
GutierrezRamos, JC .
JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 185 (01) :111-120
[2]   HIV blocked by chemokine antagonist [J].
ArenzanaSeisdedos, F ;
Virelizier, JL ;
Rousset, D ;
ClarkLewis, I ;
Loetscher, P ;
Moser, B ;
Baggiolini, M .
NATURE, 1996, 383 (6599) :400-400
[3]   Human chemokines: An update [J].
Baggiolini, M ;
Dewald, B ;
Moser, B .
ANNUAL REVIEW OF IMMUNOLOGY, 1997, 15 :675-705
[4]   The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry [J].
Bleul, CC ;
Farzan, M ;
Choe, H ;
Parolin, C ;
ClarkLewis, I ;
Sodroski, J ;
Springer, TA .
NATURE, 1996, 382 (6594) :829-833
[5]   A highly efficacious lymphocyte chemoattractant, stromal cell-derived factor 1 (SDF-1) [J].
Bleul, CC ;
Fuhlbrigge, RC ;
Casasnovas, JM ;
Aiuti, A ;
Springer, TA .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 184 (03) :1101-1109
[6]  
Brunger A.T, 1993, XPLOR VERSION 31 SYS
[7]  
CLARKLEWIS I, 1994, J BIOL CHEM, V269, P16075
[8]   STRUCTURE-ACTIVITY-RELATIONSHIPS OF CHEMOKINES [J].
CLARKLEWIS, I ;
KIM, KS ;
RAJARATHNAM, K ;
GONG, JH ;
DEWALD, B ;
MOSER, B ;
BAGGIOLINI, M ;
SYKES, BD .
JOURNAL OF LEUKOCYTE BIOLOGY, 1995, 57 (05) :703-711
[9]   FUSION FROM WITHOUT DIRECTED BY HUMAN-IMMUNODEFICIENCY-VIRUS PARTICLES [J].
CLAVEL, F ;
CHARNEAU, P .
JOURNAL OF VIROLOGY, 1994, 68 (02) :1179-1185
[10]   Change in coreceptor use correlates with disease progression in HIV-1-infected individuals [J].
Connor, RI ;
Sheridan, KE ;
Ceradini, D ;
Choe, S ;
Landau, NR .
JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 185 (04) :621-628